4 relationships in the loaded graph sample, not the complete network. Includes unconfirmed leads, labelled separately. Read each row from subject to counterpart. Accounting consolidation is not a claim of equity ownership. A relationship does not transfer sanctions status or establish wrongdoing.
Sources represented: GLEIF Level 2. Counts describe this displayed sample, not all records or all possible chains.
| Subject | Relationship | Counterpart | Dates & evidence |
|---|---|---|---|
| Kemofarmacija, Veletrgovina Za Oskrbo Zdravstva, D.d. | Ultimate accounting consolidation intoDiscovery lead — unconfirmed | PHOENIX Pharmahandel GmbH & Co KG | Current in source snapshotFrom: 2022-11-01
|
| Kemofarmacija, Veletrgovina Za Oskrbo Zdravstva, D.d. | Direct accounting consolidation intoDiscovery lead — unconfirmed | PHOENIX International Holdings GmbH | Current in source snapshotFrom: 2022-11-01
|
| Kemofarmacija, Veletrgovina Za Oskrbo Zdravstva, D.d. | Ultimate accounting consolidation intoDiscovery lead — unconfirmed | MCKESSON CORPORATION | Not current in sourceFrom: 2014-01-01To: 2022-11-01
|
| Kemofarmacija, Veletrgovina Za Oskrbo Zdravstva, D.d. | Direct accounting consolidation intoDiscovery lead — unconfirmed | McKesson Europe AG | Not current in sourceFrom: 2004-01-01To: 2022-11-01
|
Selected paths from the loaded sample, not a count of all chains. Each step retains its reported direction and evidence. A path does not establish common control, simultaneous activity or wrongdoing.
Exploratory path — includes unconfirmed steps · incomplete dates
Discovery lead — unconfirmed · Current in source snapshot · From: 2022-11-01
GLEIF Level 2
Source-attributed relationship · Current in source snapshot · From: 2018-05-28
GLEIF Level 2
Exploratory path — includes unconfirmed steps · incomplete dates
Discovery lead — unconfirmed · Current in source snapshot · From: 2022-11-01
GLEIF Level 2
Source-attributed relationship · Current in source snapshot · From: 2018-05-28
GLEIF Level 2
Exploratory path — includes unconfirmed steps · incomplete dates
Discovery lead — unconfirmed · Current in source snapshot · From: 2022-11-01
GLEIF Level 2
Source-attributed relationship · Current in source snapshot · From: 2017-09-26
GLEIF Level 2
Exploratory path — includes unconfirmed steps · incomplete dates
Discovery lead — unconfirmed · Current in source snapshot · From: 2022-11-01
GLEIF Level 2
Source-attributed relationship · Current in source snapshot · From: 2018-05-28
GLEIF Level 2
Exploratory path — includes unconfirmed steps · incomplete dates
Discovery lead — unconfirmed · Current in source snapshot · From: 2022-11-01
GLEIF Level 2
Source-attributed relationship · Current in source snapshot · From: 2018-04-23
GLEIF Level 2
Exploratory path — includes unconfirmed steps · incomplete dates
Discovery lead — unconfirmed · Current in source snapshot · From: 2022-11-01
GLEIF Level 2
Source-attributed relationship · Current in source snapshot · From: 2018-05-28
GLEIF Level 2
Patterns in the loaded graph sample. Includes weak leads; shared addresses and management do not establish common ownership, meetings or wrongdoing. Dates may differ.
Through PHOENIX Pharmahandel GmbH & Co KG
Exploratory lead — review each step
incomplete dates · 13 loaded steps
Explore connector →Through MCKESSON CORPORATION
Exploratory lead — review each step
incomplete dates · 8 loaded steps
Explore connector →Broad discovery graph with explicit confidence tiers. Candidate links never create a sanctions status.
SWIFT © and database rights September 2026. All rights reserved. This Mapping Table has been developed by SWIFT. Any use of the Mapping Table, in whole or in part, is subject to the BIC/LEI Mapping Table License Agreement as published with the Mapping Table available on GLEIF’s website. The Mapping Table is updated monthly. For the latest BIC information and updates, always refer to www.swift.com/bic.
"Public-record notice: Kemofarmacija, Veletrgovina Za Oskrbo Zdravstva, D.d. appears in public source record data. The record is informational and should be checked against the original publisher before legal, financial or counterparty decisions are made."
This public record does not establish a banking prohibition. Any onboarding or transaction decision should use the original source, a verified identity match and the institution's applicable legal framework.
This sanctions reference has not been classified as a direct record from an approved official list. It must not be relied upon as proof of designation.
| Full Legal Name | Kemofarmacija, Veletrgovina Za Oskrbo Zdravstva, D.d. |
| Source datasets | EU ESMA SARISeu_esma_saris |
| Record status | Informational public record |
| Identifiers | 485100OOVR9XX5XQVQ74 |
| Record timeline | First seen: 2026-01-12T19:07:01 • Last seen: 2026-10-28T19:07:04 |
| Risk Topics | reg.action, reg.warn, sanction |
Independent assessment
SIC Group prepares source-backed risk context, exposure memos, and remediation pathways for entities seeking to clarify a public record or counterparty signal.